IN THE PRESS
Press Releases
Read all Press Releases-
-
Alltrna Pioneers New Processes to Synthesize Chemically Modified tRNAs
-
Alltrna Applies Machine Learning to Engineer tRNA Oligonucleotides with Significantly Improved Activity and Demonstrates In Vivo Readthrough of the Two Most Common Premature Termination Codons in Genetic Disease
-
Alltrna Announces Presentations at ASGCT 27th Annual Meeting and TIDES USA 2024
-
Alltrna Expands Leadership Team with Appointments of Chief Scientific Officer and Chief Technology Officer
-
Drug Target Review Podcast: Scaling Genetic Medicine with tRNA
-
Nucleic Acid Insights: Advancing Treatment of Genetic Diseases through Engineered tRNA Therapeutics
-
RARECast: A No-Nonsense Effort to Develop a Therapy that Works Across Genetic Diseases
-
The Genetics Podcast (Episode 139): Rare Disease Breakthroughs Using tRNA with Michelle Werner, CEO of Alltrna and CEO-Partner of Flagship Pioneering
-
Alltrna Featured on Fast Company’s 2024 World Changing Ideas List for Advancing a Universal tRNA Medicine for Stop Codon Disease